Related Experiment Video
Updated: Jan 19, 2026

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination
Published on: February 9, 2021
Near-infrared photoimmunotherapy through bone.
Yu A Nakamura1, Shuhei Okuyama1, Aki Furusawa1
1Molecular Imaging Program, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA.
Near-infrared photoimmunotherapy (NIR-PIT) effectively treats bone cancers by targeting cancer cells with light. This study demonstrates NIR-PIT
Area of Science:
- Oncology
- Biomedical Engineering
- Photomedicine
Background:
- Near-infrared photoimmunotherapy (NIR-PIT) utilizes targeted conjugates and NIR light for selective cancer cell death.
- Bone cancers pose treatment challenges due to poor light penetration through bone tissue.
Purpose of the Study:
- To evaluate the efficacy of NIR-PIT in treating cancer within bone.
- To determine if NIR-PIT can overcome light penetration limitations in bone tissue.
Main Methods:
- In vitro and in vivo models using bovine rib bone samples were employed.
- NIR-PIT was administered, followed by irradiation at specific dosages (64-1500 J/cm²).
- Tumor cell viability was assessed using bioluminescence and cytotoxicity assays.
Main Results:
- In vitro studies showed significant tumor cell death with NIR-PIT irradiation through bone.
- In vivo mouse models demonstrated a significant reduction in tumor viability post-NIR-PIT treatment through bone.
- P-values of .026 and .040 indicated statistical significance in tumor reduction.
Conclusions:
- NIR-PIT is effective in treating bone cancers, even with limited light transmission.
- The study validates NIR-PIT as a viable therapeutic option for osseous malignancies.
More Related Videos
05:18Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Published on: March 14, 2016
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025